JorgensenR., and WulffM., The effect of orally administered chlorpromazine on the electroencephalogram of man, Electroenceph. Clin. Neurophysiol., 10:325–329, 1958.
2.
HollisterL., and BarthelC., Changes in the electroencephalogram during chronic administration of tranquilizing drugs, Electoenceph. Clin. Neurophysiol., 11:792–795, 1959.
3.
KooiK., and BennettJ., The effects of phenothiazine derivatives on the electroencephalogram, Electroenceph. Clin. Neurophysiol., 12:755–756, 1960.
4.
FinkM., Quantitative EEG in human psychopharmacology: II. Drug patterns, In GlaserG.H. (ed.): EEG and Behavior, New York, Basic Books, 1973, pp 177–197.
5.
FinkM., Quantitative EEG and psychopharmacology: III. Changes on acute and chronic administration of chlorpromazine, imipramine, and placebo, In WilsonW.P. (ed.): Applications of Electroencephalography in Psychiatry, Durham, Duke Univ. Press, 1965, pp 226–240.
6.
GoldsteinL., Electro-cerebral activity in schizophrenics and non-psychotic subjects: Quantitative EEG amplitude analysis, Electroenceph. Clin. Neurophysiol;19:350–361, 1965.
7.
LogothetisJ., Spontaneous epileptic seizures and electroencephalographic changes in the courses of phenothiazine therapy, Neurology, 17:869–877, 1967.
8.
ItilT., Differentiation of psychotropic drugs by quantitative EEG analysis, Aggressologie, 9:267–280, 1968.
9.
LibersonW., Individual differences in the EEG effects of chlorpromazine, Electroenceph. Clin. Neurophysiol;9:159, 1957.
10.
UlettG., The effect of psychotropic drugs on the EEG of the chronic psychotic patient, In WilsonW.P. (ed.): Applications of Electroencephalography in Psychiatry, Durham, Duke Univ. Press, 1965, pp 241–257.
11.
HelmchenH., and KonkelH., The EEG in psychiatric pharmacology, Electroenceph. Clin. Neurophysiol., 20:276, 1966.
12.
ItilT., Electroencephalography and pharmacopsychiatry, In FreyhanF. (eds.): Modern Problems of Pharmocopsychiatry, Vol. 1, Basel, S. Karger, 1968, pp 163–194.
13.
DasbergH., and RobinsonS., Correlation between electroencephalographic deviations following anti-psychotic drug treatment and the course of mental illness, Isr. Ann. Psychiat. Rel. Disc., 7:185–200, 1969.
14.
RobinsonS. and DasbergH., Observations on mellaril-induced EEG changes in mental patients and their relationship to course and outcome of the illness, Isr. Ann. Psychiat. Rel. Disc., 7:201–212, 1969.
15.
DasbergH., and RobinsonS., Electroencephalographic variations following antipsychotic drug treatment, Dis. Nerv. Syst., 32:472–478, 1971.
16.
SugarmanA., EEG and behavioral changes in schizophrenia. Arch. Gen. Psychiat., 10:340–344, 1964.
17.
WinfieldD., and AivazianG., EEG changes associated with intensive sparine therapy, Electroenceph. Clin. Neurophysiol., 10:575, 1958.
18.
BenteD., Elektroencephalographic und Psychiatrische Pharmakotherapie, In AchelisJ.D., and v. DitfurthH. (eds.): Anthropologische und Naturwissenschaftlicheklinische Grundlagenprobleme der Pharmakopsychiatrie, Stuttgart, G. Thieme, 1963, pp 75–97.
19.
ItilT. : Effect of sulthiame in schizophrenic patients, Proc. 1st Int. Congr. Acad. Psychosom. Med., Mallorca, Excerpta Med. Found., Int. Congr. Series, No. 134:185–194, 1967.
20.
GibbsF., and GibbsE., Atlas of Electroencephalography, Cambridge/Reading, Mass., Addison-Wesley Press, 1950-1964.
21.
Committee on nomenclature and statistics: Diagnostic and Statistical Manual of Mental Disorders, ed. 2, Washington, D.C., American Psychiatric Association, 1968.
22.
Van LeeuwenW.S., Proposal for an EEG terminology by the terminology committee of the international federation for electroencephalography and clinical neurophysiology, Electroenceph. Clin. Neurophysiol., 20:306–310, 1966.
23.
TuckerG., Behavior and symptoms of psychiatric patients and the electroencephalogram, Arch. Gen. Psychiat.12:278–286, 1965.
24.
RochfordJ., Neuropsychological impairments in functional psychiatric diseases, M.D. Thesis, Yale Univ. School of Medicine, 1969.
25.
RochfordJ., Neuropsychological impairments in functional psychiatric diseases, Arch. Gen. Psychiat.22:114–119, 1970.
26.
HollisterL., Choice of antipsychotic drugs, Am. J. Psychiat.127:186–190, 1970.
27.
ItilT., Convulsive and anticonvulsive properties of neuro-psycho-pharmaca, In NiedermeyerE. (ed.): Modern Problems of Pharmacopsychiatry, Vol. 4, Epilepsy, Basel, S. Karger, 1970, pp 270–305.
28.
PincusJ., and GlaserG., The syndrome of “minimal brain damage” in childhood, N. Engl. J. Med., 275:27–35, 1966.
29.
HertzigM., and BirchH., Neurologic organization in psychiatrically disturbed adolescents, Arch. Gen. Psychiat.19:528–537, 1968.
30.
MonroeR., and MickleW., Alpha chloraloseactivated electroencephalograms in psychiatric patients, J. Nerv. Ment. Dis., 144:59–68, 1967.
31.
MonroeR., Episodic Behavioral Disorders: A Psychodynamic and Neurophysiologic Analysis, Cambridge, Harvard Univ. Press, 1970, p. 517.
32.
YamadaT., Heterogeneity of schizophrenia as demonstrable in electroencephalography, In MitsudaH. (ed.): Clinical Genetics in Psychiatry, Tokyo, Igaku Shoin Ltd., 1967, pp 197–208.
33.
HillD., EEG in episodic psychotic and psychopathic behavior: A classification of data, Electroenceph. Clin. Neurophysiol., 4:419–442, 1952.
34.
MarkV., and ErvinF., Violence and the Brain, New York, Harper and Row, 1970, p 170.
35.
JonasA., Ictal and Subictal Neurosis: Diagnosis and Treatment, Springfield, III., Chas. C. Thomas, 1965, p 1228.
36.
JonasA., The emergence of epileptic equivalents in the era of tranquilizers, Int. J. Neuropsychiatry, 3:40–45, 1967.
37.
MonroeR., and WiseS., Combined phenothiazine, chlordiazepoxide, and primadone therapy for uncontrolled psychotic patients, Am. J. Psychiat.122:694–698, 1965.
38.
UlettG., A study of the behavior and EEG patterns of patients receiving tranquilizers with and without the addition of chlordiazepoxide, J. Neuropsychiat.5:558–565, 1964.
WhiteP., EEG abnormalities in early childhood schizophrenia: A double-blind study of psychiatrically disturbed and normal children during promazine sedation, Am. J. Psychiat.120:950–958, 1964.
41.
BorensteinP., Clinical and experimental electroencephalography, In BobonD.P. (eds.): Modern Problems of Pharmacopsychiatry, Vol. 5, The Neuroleptics, Basel, S. Karger, 1970, pp 109–125.
42.
KennardM., The value of equivocal signs in neurologic diagnosis, Neurology, 10:754–764, 1960.